The research team concluded that early detection and gene therapy may offer the best results among infants diagnosed with Canavan disease. Canavan disease is a rare inherited neurological disorder with devastating effect. The lack of a specific enzyme, called aspartoacylase, causes the body's central nervous system to break down. The disease is usually fatal before a child reaches the teenage years.
